Alzheimer’s Disease II

1. Targets and Strategies Toward the Development of Alzheimer Therapeutics
Michael S. Wolfe

2. The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer’s Disease
Arun K. Ghosh, Emilio L. Cárdenas, Heather L. Osswald

3. γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease
Douglas S. Johnson, Martin Pettersson

4. Inhibitors of Tau-Phosphorylating Kinases
Anna Lucia Fallacara, Iuni Margaret Laura Trist, Silvia Schenone, Maurizio Botta

5. Microtubule-Stabilizing Agents for Alzheimer’s and Other Tauopathies
Carlo Ballatore, Amos B. Smith, Virginia M.-Y. Lee, John Q. Trojanowski, Kurt R. Brunden

6. PET Imaging Agents for Alzheimer’s Disease
Seok Rye Choi, Karl Ploessl, Lin Zhu, Hank F. Kung

Nyckelord: Chemistry, Medicinal Chemistry, Pharmaceutical Sciences/Technology, Receptors, Neurosciences